These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26379118)

  • 21. The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line.
    Price JT; Quinn JM; Sims NA; Vieusseux J; Waldeck K; Docherty SE; Myers D; Nakamura A; Waltham MC; Gillespie MT; Thompson EW
    Cancer Res; 2005 Jun; 65(11):4929-38. PubMed ID: 15930315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair.
    Koll TT; Feis SS; Wright MH; Teniola MM; Richardson MM; Robles AI; Bradsher J; Capala J; Varticovski L
    Mol Cancer Ther; 2008 Jul; 7(7):1985-92. PubMed ID: 18645008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells.
    Ko JC; Chen HJ; Huang YC; Tseng SC; Weng SH; Wo TY; Huang YJ; Chiu HC; Tsai MS; Chiou RY; Lin YW
    Regul Toxicol Pharmacol; 2012 Dec; 64(3):415-24. PubMed ID: 23069143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.
    Madrigal-Matute J; López-Franco O; Blanco-Colio LM; Muñoz-García B; Ramos-Mozo P; Ortega L; Egido J; Martín-Ventura JL
    Cardiovasc Res; 2010 May; 86(2):330-7. PubMed ID: 20154064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schedule-dependent synergy between the heat shock protein 90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin and doxorubicin restores apoptosis to p53-mutant lymphoma cell lines.
    Robles AI; Wright MH; Gandhi B; Feis SS; Hanigan CL; Wiestner A; Varticovski L
    Clin Cancer Res; 2006 Nov; 12(21):6547-56. PubMed ID: 17085670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-335 inhibits small cell lung cancer bone metastases via IGF-IR and RANKL pathways.
    Gong M; Ma J; Guillemette R; Zhou M; Yang Y; Yang Y; Hock JM; Yu X
    Mol Cancer Res; 2014 Jan; 12(1):101-10. PubMed ID: 23966614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heat shock protein 90-sheltered overexpression of insulin-like growth factor 1 receptor contributes to malignancy of thymic epithelial tumors.
    Breinig M; Mayer P; Harjung A; Goeppert B; Malz M; Penzel R; Neumann O; Hartmann A; Dienemann H; Giaccone G; Schirmacher P; Kern MA; Chiosis G; Rieker RJ
    Clin Cancer Res; 2011 Apr; 17(8):2237-49. PubMed ID: 21372220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis.
    Madrigal-Matute J; Fernandez-Garcia CE; Gomez-Guerrero C; Lopez-Franco O; Muñoz-Garcia B; Egido J; Blanco-Colio LM; Martin-Ventura JL
    Cardiovasc Res; 2012 Jul; 95(1):116-23. PubMed ID: 22547655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells.
    Kurashina R; Ohyashiki JH; Kobayashi C; Hamamura R; Zhang Y; Hirano T; Ohyashiki K
    Cancer Lett; 2009 Oct; 284(1):62-70. PubMed ID: 19464103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P-glycoprotein confers acquired resistance to 17-DMAG in lung cancers with an ALK rearrangement.
    Kim HJ; Lee KY; Kim YW; Choi YJ; Lee JE; Choi CM; Baek IJ; Rho JK; Lee JC
    BMC Cancer; 2015 Jul; 15():553. PubMed ID: 26219569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heat shock protein 90 is a promising target for effective growth inhibition of gastrointestinal neuroendocrine tumors.
    Gloesenkamp C; Nitzsche B; Lim AR; Normant E; Vosburgh E; Schrader M; Ocker M; Scherübl H; Höpfner M
    Int J Oncol; 2012 May; 40(5):1659-67. PubMed ID: 22246317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and Evaluation of a Novel Deguelin Derivative, L80, which Disrupts ATP Binding to the C-terminal Domain of Heat Shock Protein 90.
    Lee SC; Min HY; Choi H; Kim HS; Kim KC; Park SJ; Seong MA; Seo JH; Park HJ; Suh YG; Kim KW; Hong HS; Kim H; Lee MY; Lee J; Lee HY
    Mol Pharmacol; 2015 Aug; 88(2):245-55. PubMed ID: 25976766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors.
    Centenera MM; Gillis JL; Hanson AR; Jindal S; Taylor RA; Risbridger GP; Sutherland PD; Scher HI; Raj GV; Knudsen KE; Yeadon T; ; Tilley WD; Butler LM
    Clin Cancer Res; 2012 Jul; 18(13):3562-70. PubMed ID: 22573351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ganetespib for small cell lung cancer.
    Subramaniam DS; Warner EA; Giaccone G
    Expert Opin Investig Drugs; 2017 Jan; 26(1):103-108. PubMed ID: 27922280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice.
    Yamada T; Muguruma H; Yano S; Ikuta K; Ogino H; Kakiuchi S; Hanibuchi M; Uehara H; Nishioka Y; Sone S
    Mol Cancer Ther; 2009 Jan; 8(1):119-26. PubMed ID: 19139120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MGr1-Ag promotes invasion and bone metastasis of small-cell lung cancer in vitro and in vivo.
    Zhang F; Wang Y; Xu M; Dong H; Liu N; Zhou J; Pang H; Ma N; Zhang N; Pei Y; Zhang H; Liu L
    Oncol Rep; 2013 Jun; 29(6):2283-90. PubMed ID: 23588894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The conformation-specific Hsp90 inhibition interferes with the oncogenic RAF kinase adaptation and triggers premature cellular senescence, hence, acts as a tumor suppressor mechanism.
    Kanugovi Vijayavittal A; Amere Subbarao S
    Biochim Biophys Acta Mol Cell Res; 2021 Mar; 1868(3):118943. PubMed ID: 33359710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring therapeutic response of human ovarian cancer to 17-DMAG by noninvasive PET imaging with (64)Cu-DOTA-trastuzumab.
    Niu G; Li Z; Cao Q; Chen X
    Eur J Nucl Med Mol Imaging; 2009 Sep; 36(9):1510-9. PubMed ID: 19440708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion.
    Tsutsumi S; Scroggins B; Koga F; Lee MJ; Trepel J; Felts S; Carreras C; Neckers L
    Oncogene; 2008 Apr; 27(17):2478-87. PubMed ID: 17968312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of premature senescence by hsp90 inhibition in small cell lung cancer.
    Restall IJ; Lorimer IA
    PLoS One; 2010 Jun; 5(6):e11076. PubMed ID: 20552022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.